Kingston, RI, United States of America

Donald Engleman

This inventor holds 1 USPTO granted patent. Top assignee: Cybrexa 1, Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Donald Engleman. Retrieved from https://idiyas.com/inventor/donald-engleman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Donald Engleman

Introduction

Donald Engleman is an accomplished inventor based in Kingston, Rhode Island. He has made significant contributions to the field of medical treatments, particularly focusing on diseases involving acidic or hypoxic diseased tissues. His innovative work has led to the development of valuable pharmaceutical compositions.

Latest Patents

Engleman holds a patent for "Methods for treatment of diseases involving acidic or hypoxic diseased tissues." This patent includes compounds for treating diseases characterized by acidic or hypoxic conditions, along with pharmaceutical compositions that comprise these compounds. The patent also outlines methods for making and using these compounds and compositions. He has 1 patent to his name.

Career Highlights

Engleman is currently associated with Cybrexa Therapeutics, a company dedicated to advancing cancer therapies. His work at Cybrexa has allowed him to apply his innovative ideas in a practical setting, contributing to the development of new treatment options.

Collaborations

Engleman has collaborated with notable colleagues, including Daniel Richard Marshall and Johanna Marie Csengery. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Donald Engleman is a notable inventor whose work in medical treatments has the potential to impact many lives. His innovative approaches to addressing complex health issues demonstrate the importance of research and collaboration in the field of medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…